AwesomeAvani

ESPR a penny and medtech stock LONG

看多
AwesomeAvani 已更新   
BATS:ESPR   Esperion Therapeutics, Inc.
ESPR on the 120-minute chart is surging with momentum from an FDA approval for a new

cholestrol and lipid medication which will be an alternative to the at statin class which has

side effects and can cause diabetes. I am familar with a few of the professionals on the

science advisory board they are researchers and academics of the highest claiber. The chart

shows price testing and getting support from the mean VWAP and a little bit of resistance

from the first upper VWAP line. I have added to my existing position at the consolidation at

VWAP. I am well informed on ESPR market prospects; this could be disruptive.

The dual time frame RSI of Chris Moody has curled up and validates the idea. My interim

target is the double top of this past winter. I do expect increasing volume in time with the

price action that follows.

Disclaimer This a hot penny stock highly volatile - you could lose on this trade. Do not trade

with money you cannot afford to lose. You must manage the trade well to realize profit.

There are options if the put to call ratio is rising big money is pushing a reversal
評論:
Nice action today. 25% of the position is closed.
交易進行:
More volatility buying and selling zig zag fashion
交易進行:
Price has ran up more than 20%- and is now in the upper VWAP bands and the upper
boundary of the Donchain channel. I am watching for an exit signal. The forecasting
algo suggests it is coming in the next few trading sessions.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。